Top Tweets for #RhoReflections
When one CRO provides both data management and biostatistics/programming services for a #clinicaltrial, there are many ways you can benefit. Heather Kopetskie outlines the perks to merging #biometrics services in her new blog: https://t.co/6oxR1j3YDD #RhoReflections
Dr. Jack Modell, chief medical officer, and Gerald Finken, CEO and pharmacists at RxE2, outline the key role community pharmacists play in helping increase the diversity of future #clinicaltrials in a new article: https://t.co/MvvhubT759 #RhoReflections
As the #covid19 generation, are we at risk for an increase in future #movementdisorders and #parkinsonsdisease? Researchers have conducted a study to answer this question.
Tune in Thursday, June 29, to learn more: https://t.co/QZ4BAewMQS #RhoReflections #webinar
This week, Dr. Marc Pipas, Dr. Kevin Barber and Dr. Joseph Watson sit down to discuss how to fill gaps in #oncology drug development and the importance of early-phase and end-of-phase planning in clinical trials. Tune in to learn more: https://t.co/3hQBJMyWkN #RhoReflections
In the latest issue of @Clin_Trials, Michael Pace, Ph.D., Associate Director of Global Feasibility at Rho, outlines key benefits and limitations of common data tools as well as tips for getting clinical studies off on the right foot: https://t.co/qEQ3Nqlt9i #RhoReflections
Sponsors should ask their CROs several key questions at the start of a clinical pharmacology program. Amanda Mathis, Ph.D., Director of Clinical Pharmacology, shares her expert advice in the latest Rho blog post: https://t.co/wiEHSmxqEP #RhoReflections
Pete Schmidt, Ph.D., senior vice president, government partnerships, was a guest on the 2 Mikes Parkinson’s Podcast! Listen to his take on recent clinical research exploring connections between #COVID19 and #Parkinsons: https://t.co/UOi07BYKdv #RhoReflections #parkinsonsawareness
Check out Rho in the news! J. Marc Pipas, MD, a clinical oncologist and industry veteran, is a Senior Medical Director at Rho. Learn more about Marc and his vision for growth here: https://t.co/hIMWE42rYo #RhoReflections
Today marks the start of #NationalInfluenzaVaccinationWeek. Our very own Peter Schmidt, Ph.D., senior vice president, government partnerships, discusses his thoughts on the future of vaccine research in @BioPharmaDive’s industry report: https://t.co/tG6I1eCb8B #RhoReflections
Curious how to tailor your #clinicaltrial strategy? Read Feasibility Manager Michael Pace’s new article discussing how to best create comprehensive, data-driven studies: https://t.co/vka618dVZN #RhoReflections
In a new article, Feasibility Manager Michael Pace, Ph.D. discusses how the #clinicaltrial industry can create comprehensive, data-driven studies using innovative feasibility tools and data platforms. Read more here: https://t.co/vka618vwRl #RhoReflections
Dr. Pete Schmidt, Senior Vice President of Government Partnerships, contributed to a study examining whether prior infection of #COVID19 increased sensitivity to a mitochondrial toxin known to induce parkinsonism. Watch this webinar: https://t.co/XA8GHaskbj #RhoReflections
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers